(Q40741932)

23 September 2017

Dengue haemorrhagic fever and dengue shock syndrome: are they tumour necrosis factor-mediated disorders? (English)

1 reference

23 September 2017

0 references

0 references

dengue shock syndrome

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

1 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

1 December 2022

author name string

M. Yadav

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1815710

1 December 2022

K. R. Kamath

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1815710

1 December 2022

N. Iyngkaran

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1815710

1 December 2022

M. Sinniah

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1815710

1 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1815710

1 December 2022

publication date

1 December 1991

1 reference

FEMS microbiology immunology

23 September 2017

1 reference

23 September 2017

4

1 reference

23 September 2017

1

1 reference

23 September 2017

45-49

1 reference

Mosquito-borne haemorrhagic fevers of South and South-East Asia

23 September 2017

1

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

The Alexander D. Langmuir Lecture. The pathogenesis of dengue. Molecular epidemiology in infectious disease

1 December 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

Antibody-enhanced dengue virus infection in primate leukocytes

1 December 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

Antibody-dependent enhancement of dengue 2 virus in people of white descent in Cuba

1 December 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

Dengue virus isolation by antibody-dependent enhancement of infectivity in macrophages

1 December 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

Clinical and laboratory observations on patients with primary and secondary dengue type 1 infections with hemorrhagic manifestations in Fiji

1 December 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

Shock syndrome in primary dengue infections

1 December 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

Cachectin: more than a tumor necrosis factor

1 December 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

The common mediator of shock, cachexia, and tumor necrosis.

1 December 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

Antiviral effects of recombinant tumour necrosis factor in vitro

1 December 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons

1 December 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

Tumor necrosis factor mediated cytolysis requires the adenovirus E1a protein but not the transformed phenotype

1 December 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses

1 December 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

Antibody-capture ELISA for detection of immunoglobulin M antibodies in sera from Japanese encephalitis and dengue hemorrhagic fever patients

1 December 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

Tumour necrosis factor in man: clinical and biological observations

1 December 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

1 December 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation

1 December 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease

1 December 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

Roles of tumour necrosis factor in the illness and pathology of malaria

1 December 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

Effect of dengue virus-induced cytotoxin on capillary permeability

1 December 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1

1 December 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

1 December 2022

Interleukin-1.

30

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

1 December 2022

33

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1991.TB04969.X

1 December 2022

Identifiers

0 references

1 reference